Erratum: Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study

Affiliations

¹ Clinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), London, UK.
² Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
³ John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁴ Kadoorie Centre for Critical Care Research and Education, NIHR Biomedical Research Centre, Oxford, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁵ UK Renal Registry, Bristol, UK.
⁶ Population Health Sciences, University of Bristol, Bristol, UK.
⁷ Department of Clinical and Experimental Medicine, Faculty of Health Sciences, University of Surrey, Guildford, UK.
⁸ Intensive Care Unit, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
⁹ Patient representative, Oxford, UK.
¹⁰ Department of Intensive Care, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Free article

Published Erratum

Doug W Gould et al. Health Technol Assess. 2022 Apr.

Free article

. 2022 Apr;26(13):85-86.

doi: 10.3310/ZXHI9396-c202204.

¹ Clinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), London, UK.
² Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
³ John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁴ Kadoorie Centre for Critical Care Research and Education, NIHR Biomedical Research Centre, Oxford, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁵ UK Renal Registry, Bristol, UK.
⁶ Population Health Sciences, University of Bristol, Bristol, UK.
⁷ Department of Clinical and Experimental Medicine, Faculty of Health Sciences, University of Surrey, Guildford, UK.
⁸ Intensive Care Unit, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
⁹ Patient representative, Oxford, UK.
¹⁰ Department of Intensive Care, Guy's and St Thomas' NHS Foundation Trust, London, UK.

No abstract available

Erratum for

Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
Gould DW, Doidge J, Sadique MZ, Borthwick M, Hatch R, Caskey FJ, Forni L, Lawrence RF, MacEwen C, Ostermann M, Mouncey PR, Harrison DA, Rowan KM, Young JD, Watkinson PJ. Gould DW, et al. Health Technol Assess. 2022 Feb;26(13):1-58. doi: 10.3310/ZXHI9396. Health Technol Assess. 2022. PMID: 35212260 Free PMC article.

1. Gould DW, Doidge J, Sadique MZ, Borthwick M, Hatch R, Caskey FJ, et al. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study. Health Technol Assess 2022;26(13).